Pulse Explorar nav.journalClub Debates Tendencias Investigadores Revistas

Inicio Explorar nav.journalClub Tendencias

⌘+K

Interleukin 6 drives durable T cell-mediated immunity to pancreatic cancer | Synapse

March 21, 2026Cellular and Molecular Gastroenterology and Hepatology1 citationsOpen Access

Interleukin 6 drives durable T cell-mediated immunity to pancreatic cancer

Ver artículo completo

PAPaige C. Arneson-WissinkOregon Health & Science University ABAlexandra Q. BartlettOregon Health & Science University HMHeike MendezOregon Health & Science University

Puntos clave

This research aims to explore the role of interleukin 6 in enhancing T cell responses against pancreatic cancer.
Assessment of IL-6 concentrations in tumor microenvironments
Evaluation of T cell anti-tumor responses
Comparison of PDAC responses with varying IL-6 levels
High IL-6 levels correlate with stronger T cell-mediated responses against pancreatic tumors
Enhanced tumor control observed in the presence of elevated IL-6 concentrations

Resumen

Locally high IL-6 concentrations potently enhance the T cell-mediated anti-tumor response to PDAC.

Preguntar a la IA

Me gusta

Guardar

Compartir

Ver artículo completo

Preguntar a la IA

Me gusta

Guardar

Compartir

Ver artículo completo

Cite This Study

Arneson-Wissink et al. (2026) studied this question.

synapsesocial.com/papers/69be35166e48c4981c67336e https://doi.org/https://doi.org/10.1016/j.jcmgh.2026.101768

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Induction of T-cell Immunity Overcomes Complete Resistance to PD-1 and CTLA-4 Blockade and Improves Survival in Pancreatic Carcinoma2015 · 473 citations
2Optimization of lipid nanoparticles for the delivery of nebulized therapeutic mRNA to the lungs2021 · 489 citations
3Lipid Nanoparticle-Delivered Chemically Modified mRNA Restores Chloride Secretion in Cystic Fibrosis2018 · 271 citations
4Improved localized mRNA delivery using lipid nanoparticles with a novel synthetic cholesterol derivative2025 · 4 citations
5Cutting Edge: Re-evaluating the In Vivo Cytokine Responses of CD8+ T Cells during Primary and Secondary Viral Infections2005 · 150 citations